Decoding argenx's Options Activity: What's the Big Picture?

Whales with a lot of money to spend have taken a noticeably bearish stance on argenx.

Looking at options history for argenx ARGX we detected 8 trades.

If we consider the specifics of each trade, it is accurate to state that 37% of the investors opened trades with bullish expectations and 62% with bearish.

From the overall spotted trades, 2 are puts, for a total amount of $180,000 and 6, calls, for a total amount of $244,300.

Get Started

Earn 7.2% — No Matter What the Fed Does

Markets expect rate cuts — but your earnings don’t have to suffer. Lock in 7.2% until 2028 from ten individual bonds.

Get Started

Predicted Price Range

Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $370.0 to $380.0 for argenx during the past quarter.

Volume & Open Interest Development

Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for argenx's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of argenx's whale trades within a strike price range from $370.0 to $380.0 in the last 30 days.

argenx Option Volume And Open Interest Over Last 30 Days

Biggest Options Spotted:

About argenx

Argenx is a Dutch company focused on using its antibody engineering technology to treat rare autoimmune diseases. Vyvgart (efgartigimod) was approved in the U.S. in December 2021 as a treatment for generalized myasthenia gravis, followed by approvals in Europe and Japan in 2022.

Present Market Standing of argenx

• With a trading volume of 36,939, the price of ARGX is up by 1.07%, reaching $385.07.
• Current RSI values indicate that the stock is is currently neutral between overbought and oversold.
• Next earnings report is scheduled for 64 days from now.

Professional Analyst Ratings for argenx

A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $494.4.

• An analyst from Citigroup has decided to maintain their Buy rating on argenx, which currently sits at a price target of $591.
• An analyst from Piper Sandler has decided to maintain their Overweight rating on argenx, which currently sits at a price target of $515.
• An analyst from Wells Fargo has decided to maintain their Overweight rating on argenx, which currently sits at a price target of $470.
• Consistent in their evaluation, an analyst from Truist Securities keeps a Buy rating on argenx with a target price of $550.
• Maintaining their stance, an analyst from Scotiabank continues to hold a Sector Perform rating for argenx, targeting a price of $346.

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest argenx options trades with real-time alerts from Benzinga Pro.